tanshinone has been researched along with staurosporine in 1 studies
| Studies (tanshinone) | Trials (tanshinone) | Recent Studies (post-2010) (tanshinone) | Studies (staurosporine) | Trials (staurosporine) | Recent Studies (post-2010) (staurosporine) |
|---|---|---|---|---|---|
| 1,445 | 10 | 1,033 | 6,272 | 58 | 976 |
| Protein | Taxonomy | tanshinone (IC50) | staurosporine (IC50) |
|---|---|---|---|
| Chain A, Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | 0.0003 | |
| Chain X, Tyrosine-protein kinase Lyn | Homo sapiens (human) | 0.0013 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, CG; Xue, CC; Yu, XQ; Zhou, SF; Zhou, ZW | 1 |
1 other study(ies) available for tanshinone and staurosporine
| Article | Year |
|---|---|
Tanshinone IIB, a primary active constituent from Salvia miltiorrhiza, exerts neuroprotective effect via inhibition of neuronal apoptosis in vitro.
Topics: Abietanes; Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Caspase 3; Cells, Cultured; DNA Fragmentation; Dose-Response Relationship, Drug; Female; In Situ Nick-End Labeling; Neurons; Phenanthrenes; Pregnancy; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Salvia miltiorrhiza; Staurosporine | 2008 |